Annual SGA
$211.12 M
+$2.45 M+1.17%
December 31, 2023
Summary
- As of February 7, 2025, MDXG annual SGA is $211.12 million, with the most recent change of +$2.45 million (+1.17%) on December 31, 2023.
- During the last 3 years, MDXG annual SGA has risen by +$30.10 million (+16.63%).
- MDXG annual SGA is now -18.34% below its all-time high of $258.53 million, reached on December 31, 2018.
Performance
MDXG SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$53.52 M
-$1.89 M-3.40%
September 30, 2024
Summary
- As of February 7, 2025, MDXG quarterly SGA is $53.52 million, with the most recent change of -$1.89 million (-3.40%) on September 30, 2024.
- Over the past year, MDXG quarterly SGA has dropped by -$1.61 million (-2.93%).
- MDXG quarterly SGA is now -20.81% below its all-time high of $67.58 million, reached on June 30, 2018.
Performance
MDXG Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$463.58 M
+$88.46 M+16.02%
September 30, 2024
Summary
- As of February 7, 2025, MDXG TTM SGA is -$463.58 million, with the most recent change of +$88.46 million (+16.02%) on September 30, 2024.
- Over the past year, MDXG TTM SGA has dropped by -$677.59 million (-316.62%).
- MDXG TTM SGA is now -31787.74% below its all-time high of -$1.45 million.
Performance
MDXG TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MDXG Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.2% | -2.9% | -316.6% |
| 3 y3 years | +16.6% | +8.0% | -332.9% |
| 5 y5 years | -18.3% | +17.8% | -333.9% |
MDXG Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8.3% | -4.1% | +8.0% | at high | +40.3% |
| 5 y | 5-year | at high | +16.6% | -4.1% | +43.4% | -17.8% | +40.3% |
| alltime | all time | -18.3% | >+9999.0% | -20.8% | >+9999.0% | <-9999.0% | +40.3% |
MiMedx Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $53.52 M(-3.4%) | $218.40 M(+0.4%) |
| Jun 2024 | - | $55.40 M(+0.5%) | $217.45 M(+1.6%) |
| Mar 2024 | - | $55.13 M(+1.4%) | $214.01 M(+1.4%) |
| Dec 2023 | $211.12 M(+1.2%) | $54.35 M(+3.4%) | $211.13 M(+2.2%) |
| Sep 2023 | - | $52.57 M(+1.2%) | $206.61 M(-0.4%) |
| Jun 2023 | - | $51.95 M(-0.6%) | $207.51 M(-1.8%) |
| Mar 2023 | - | $52.25 M(+4.8%) | $211.35 M(+1.3%) |
| Dec 2022 | $208.67 M(+7.1%) | $49.84 M(-6.8%) | $208.67 M(+0.1%) |
| Sep 2022 | - | $53.48 M(-4.2%) | $208.39 M(+3.6%) |
| Jun 2022 | - | $55.79 M(+12.6%) | $201.21 M(+1.1%) |
| Mar 2022 | - | $49.57 M(+0.0%) | $199.01 M(+2.1%) |
| Dec 2021 | $194.85 M(+7.6%) | $49.55 M(+7.1%) | $194.85 M(+0.4%) |
| Sep 2021 | - | $46.29 M(-13.6%) | $194.00 M(-0.9%) |
| Jun 2021 | - | $53.60 M(+18.0%) | $195.75 M(+9.1%) |
| Mar 2021 | - | $45.40 M(-6.8%) | $179.49 M(-0.8%) |
| Dec 2020 | $181.02 M(-8.7%) | $48.71 M(+1.4%) | $181.02 M(+1.8%) |
| Sep 2020 | - | $48.05 M(+28.7%) | $177.76 M(-1.8%) |
| Jun 2020 | - | $37.33 M(-20.5%) | $180.97 M(-6.9%) |
| Mar 2020 | - | $46.94 M(+3.3%) | $194.28 M(-2.0%) |
| Dec 2019 | $198.21 M(-23.3%) | $45.44 M(-11.3%) | $198.21 M(-9.5%) |
| Sep 2019 | - | $51.26 M(+1.2%) | $219.06 M(-3.3%) |
| Jun 2019 | - | $50.64 M(-0.4%) | $226.54 M(-7.0%) |
| Mar 2019 | - | $50.86 M(-23.3%) | $243.48 M(-5.8%) |
| Dec 2018 | $258.53 M(+17.4%) | $66.30 M(+12.9%) | $258.53 M(+6.0%) |
| Sep 2018 | - | $58.74 M(-13.1%) | $243.85 M(-0.6%) |
| Jun 2018 | - | $67.58 M(+2.5%) | $245.35 M(+5.3%) |
| Mar 2018 | - | $65.91 M(+27.7%) | $233.08 M(+5.9%) |
| Dec 2017 | $220.12 M(+26.9%) | $51.62 M(-14.3%) | $220.12 M(+4.7%) |
| Sep 2017 | - | $60.23 M(+8.9%) | $210.31 M(+6.1%) |
| Jun 2017 | - | $55.31 M(+4.5%) | $198.26 M(+6.8%) |
| Mar 2017 | - | $52.95 M(+26.6%) | $185.72 M(+7.1%) |
| Dec 2016 | $173.41 M(+30.0%) | $41.81 M(-13.2%) | $173.41 M(+3.1%) |
| Sep 2016 | - | $48.18 M(+12.6%) | $168.12 M(+8.6%) |
| Jun 2016 | - | $42.77 M(+5.2%) | $154.84 M(+7.0%) |
| Mar 2016 | - | $40.65 M(+11.3%) | $144.72 M(+8.5%) |
| Dec 2015 | $133.38 M | $36.52 M(+4.7%) | $133.38 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $34.90 M(+6.9%) | $126.10 M(+9.3%) |
| Jun 2015 | - | $32.65 M(+11.4%) | $115.39 M(+11.0%) |
| Mar 2015 | - | $29.31 M(+0.2%) | $103.94 M(+14.9%) |
| Dec 2014 | $90.48 M(+95.7%) | $29.24 M(+20.9%) | $90.48 M(+19.8%) |
| Sep 2014 | - | $24.19 M(+14.2%) | $75.52 M(+17.9%) |
| Jun 2014 | - | $21.19 M(+33.7%) | $64.03 M(+19.2%) |
| Mar 2014 | - | $15.85 M(+11.0%) | $53.71 M(+16.2%) |
| Dec 2013 | $46.23 M(+136.0%) | $14.28 M(+12.3%) | $46.23 M(+15.3%) |
| Sep 2013 | - | $12.71 M(+17.0%) | $40.10 M(+21.0%) |
| Jun 2013 | - | $10.87 M(+29.9%) | $33.14 M(+30.9%) |
| Mar 2013 | - | $8.37 M(+2.7%) | $25.32 M(+29.3%) |
| Dec 2012 | $19.59 M(+99.0%) | $8.15 M(+41.5%) | $19.59 M(+44.1%) |
| Sep 2012 | - | $5.76 M(+88.8%) | $13.60 M(+33.3%) |
| Jun 2012 | - | $3.05 M(+15.6%) | $10.20 M(+3.5%) |
| Mar 2012 | - | $2.64 M(+22.5%) | $9.86 M(+0.1%) |
| Dec 2011 | $9.85 M(+43.8%) | $2.15 M(-8.6%) | $9.85 M(+4.5%) |
| Sep 2011 | - | $2.36 M(-13.0%) | $9.42 M(+9.0%) |
| Jun 2011 | - | $2.71 M(+3.1%) | $8.64 M(+11.3%) |
| Mar 2011 | - | $2.63 M(+52.2%) | $7.76 M(+13.4%) |
| Dec 2010 | $6.85 M(+97.7%) | $1.73 M(+9.3%) | $6.85 M(+33.7%) |
| Sep 2010 | - | $1.58 M(-13.8%) | $5.12 M(+2.4%) |
| Jun 2010 | - | $1.83 M(+7.0%) | $5.00 M(+11.0%) |
| Mar 2010 | - | $1.71 M(+17.3%) | $4.50 M(-26.5%) |
| Dec 2009 | $3.46 M(-56.4%) | - | - |
| Sep 2009 | - | $1.46 M(+9.4%) | $6.13 M(-13.0%) |
| Jun 2009 | - | $1.33 M(-30.1%) | $7.05 M(-11.3%) |
| Mar 2009 | - | $1.91 M(+33.7%) | $7.95 M(+31.6%) |
| Mar 2009 | $7.95 M(-8.2%) | - | - |
| Dec 2008 | - | $1.43 M(-39.9%) | $6.04 M(+30.8%) |
| Sep 2008 | - | $2.38 M(+6.2%) | $4.62 M(+105.4%) |
| Jun 2008 | - | $2.24 M(>+9900.0%) | $2.25 M(+6010.6%) |
| Mar 2008 | $8.66 M(>+9900.0%) | - | - |
| Dec 2007 | $36.80 K(+128.6%) | $7400.00(+48.0%) | $36.80 K(+25.2%) |
| Sep 2007 | - | $5000.00(-41.2%) | $29.40 K(+20.5%) |
| Jun 2007 | - | $8500.00(-46.5%) | $24.40 K(+53.5%) |
| Mar 2007 | - | $15.90 K | $15.90 K |
| Dec 2006 | $16.10 K | - | - |
FAQ
- What is MiMedx annual SGA?
- What is the all time high annual SGA for MiMedx?
- What is MiMedx annual SGA year-on-year change?
- What is MiMedx quarterly SGA?
- What is the all time high quarterly SGA for MiMedx?
- What is MiMedx quarterly SGA year-on-year change?
- What is MiMedx TTM SGA?
- What is the all time high TTM SGA for MiMedx?
- What is MiMedx TTM SGA year-on-year change?
What is MiMedx annual SGA?
The current annual SGA of MDXG is $211.12 M
What is the all time high annual SGA for MiMedx?
MiMedx all-time high annual SGA is $258.53 M
What is MiMedx annual SGA year-on-year change?
Over the past year, MDXG annual SGA has changed by +$2.45 M (+1.17%)
What is MiMedx quarterly SGA?
The current quarterly SGA of MDXG is $53.52 M
What is the all time high quarterly SGA for MiMedx?
MiMedx all-time high quarterly SGA is $67.58 M
What is MiMedx quarterly SGA year-on-year change?
Over the past year, MDXG quarterly SGA has changed by -$1.61 M (-2.93%)
What is MiMedx TTM SGA?
The current TTM SGA of MDXG is -$463.58 M
What is the all time high TTM SGA for MiMedx?
MiMedx all-time high TTM SGA is -$1.45 M
What is MiMedx TTM SGA year-on-year change?
Over the past year, MDXG TTM SGA has changed by -$677.59 M (-316.62%)